Jon E Grant, MD, JD, MPH
University of Chicago
Emerging Leaders
not ranked
Current Leaders
#15924 pts
All-Time Leaders
#3969 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2006. 5 trials as lead/chair. How it works →
Trials led — by scientific impact
A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder.
Phase 2CompletedUniversity of Chicago
10
impact
Tolcapone Treatment of Obsessive Compulsive Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Phase 3CompletedUniversity of Chicago
8
impact
A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
Phase 3CompletedUniversity of Chicago
7
impact
A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive Behaviors
Phase 2Not Yet RecruitingUniversity of Chicago
6
impact
Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors
Phase 3ActiveUniversity of Chicago
6
impact
A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder
Phase 2CompletedUniversity of Chicago
6
impact
Silymarin Treatment of Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Study
Phase 2WithdrawnUniversity of Chicago
5
impact
An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
Phase 2CompletedUniversity of Chicago
5
impact
An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study
Phase 2CompletedUniversity of Chicago
4
impact
A Double-Blind, Placebo-Controlled Study of N-Acetyl Cysteine in Pathologic Skin Picking
Phase 2CompletedUniversity of Chicago
4
impact
Flibanserin and Women With Hypoactive Sexual Desire Disorder: A Double-Blind, Randomized, Electrical Neuroimaging Study
N/ATerminatedUniversity of Chicago
4
impact
Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study
Phase 2CompletedUniversity of Chicago
2
impact
A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania
Phase 2CompletedUniversity of Chicago
1
impact
A Double-Blind Study of N-Acetyl Cysteine Plus Naltrexone in the Treatment of Methamphetamine Dependence
Phase 2CompletedUniversity of Chicago
0
impact
Valbenazine in Obsessive-compulsive Disorder: A Randomized Double-blind Placebo-controlled Crossover Trial
Phase 2Not Yet RecruitingUniversity of Chicago
0
impact
Once Weekly Semaglutide Treatment of Trichotillomania: An Open-Label Study
Phase 2Not Yet RecruitingUniversity of Chicago
0
impact
A Double-Blind, Placebo-Controlled Study of Caplyta in the Treatment of Borderline Personality Disorder
Phase 2CompletedUniversity of Chicago
0
impact
A Double-Blind, Randomized, Placebo-Controlled Study of Tolcapone for OCD
Phase 2ActiveUniversity of Chicago
0
impact
Silymarin Treatment of Trichotillomania in Children and Adults: A Double-Blind, Placebo-Controlled, Cross-Over Study
Phase 2CompletedUniversity of Chicago
0
impact